🇺🇸 FDA
Patent

US 12281310

Use of trinucleotide repeat RNAs to treat cancer

granted A61KA61K31/713A61K47/64

Quick answer

US patent 12281310 (Use of trinucleotide repeat RNAs to treat cancer) held by Northwestern University expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/713, A61K47/64, A61K47/6931, A61P